Free EBook: 15 Industry insights into how vaccine sponsors choose CROs

17 June 2013 / By Freya Smale / Partnering and Corporate strategy / 0 comments

Download the free eBook here > 15 Industry insights into how vaccine sponsors choose CROs Pharma’s increased need for partners to assist with their [...]

More in Partnering and Corporate strategy

GSK buys Okairos for $324 million in vaccine boost effort

29 May 2013 / By Tim / Featured on App, Partnering and Corporate strategy, Prophylactic Vaccines, R&D / 0 comments
India announces development of $1 rotavirus vaccine

15 May 2013 / By Tim / Emerging Markets, Featured on App, Partnering and Corporate strategy, Prophylactic Vaccines, R&D / 1 comment
GSK analyses discussion forums for parental concerns about vaccines

10 May 2013 / By Tim / Featured on App, Partnering and Corporate strategy / 0 comments
GSK and Save the Children team up to widen vaccination coverage

10 May 2013 / By Tim / Featured on App, Partnering and Corporate strategy / 0 comments
Takeda acquires Inviragen and their DENVax vaccine

8 May 2013 / By Tim / Emerging Markets, Featured on App, Partnering and Corporate strategy, Prophylactic Vaccines, R&D / 0 comments
Global Immunization Strategies and Initiatives

17 April 2013 / By Tim / Events, Featured on App, Partnering and Corporate strategy, Prophylactic Vaccines, R&D, Regulation and Policy, Therapeutic Vaccines / 0 comments
Continuous Processing: From Cookie Preparation to Cell-based Production

28 March 2013 / By Freya Smale / Partnering and Corporate strategy, R&D / 0 comments
Guest bloggers for World Vaccine Congress Washington 2013

26 March 2013 / By Freya Smale / Emerging Markets, Featured on App, Flu, Partnering and Corporate strategy, Prophylactic Vaccines, R&D, Regulation and Policy, Therapeutic Vaccines, Veterinary Vaccines / 0 comments
TOP 10 (+1) vaccine Biotechs to watch out for

4 March 2013 / By Freya Smale / Featured on App, Partnering and Corporate strategy / 0 comments
GSK announces new joint venture in emerging vaccine market – are joint ventures critical?

27 February 2013 / By Tim / Emerging Markets, Featured on App, Partnering and Corporate strategy / 0 comments